Diabetes mellitus: a hypercoagulable state (Q34190414)

31 July 2017

1 reference

title

Diabetes mellitus: a hypercoagulable state (English)

1 reference

31 July 2017

Carr ME

1

1 reference

31 July 2017

1 January 2001

1 reference

Journal of Diabetes and its Complications

31 July 2017

1 reference

31 July 2017

15

1 reference

31 July 2017

44-54

1 reference

31 July 2017

1

1 reference

Platelet-dependent thrombin generation in patients with diabetes mellitus: effects of glycemic control on coagulability in diabetes

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

1 reference

7 January 2021

Platelet and coagulation factors in proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Effect of fibrin structure on plasmin-mediated dissolution of plasma clots

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Thrombin-antithrombin III complexes in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Diminished fibrinolysis and thrombosis: clinical implications for accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Diabetes, a Hypercoagulable State? Haemostatic Variables in Newly Diagnosed Type 2 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Plasma fibrinopeptide A levels during insulin-induced plasma glucose falls in diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Hematologic alterations in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Effect of Advanced Glycation End Product–Modified Albumin on Tissue Factor Expression by Monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen)

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Change of lipoprotein (a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Contact phase of blood coagulation in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Plasma β-Thromboglobulin, Platelet Factor 4, Fibrinopeptide A, and Other Hemostatic Functions During Improved, Short-Term Glycemic Control in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

The hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Increased plasminogen activator inhibitor type 1 in coronary artery atherectomy specimens from type 2 diabetic compared with nondiabetic patients: a potential factor predisposing to thrombosis and its persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Electron microscopical studies of vessels in diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Fibrinolysis in patients with diabetic nephropathy determined by plasmin-alpha 2 plasmin inhibitor complexes in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

Increased Tissue Factor Pathway Inhibitor Activity in IDDM Patients With Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-8727%2800%2900132-X

7 January 2021

10.1016/S1056-8727(00)00132-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11259926